| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |